Singapore markets closed

Augmedix, Inc. (AUGX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.9400+0.1000 (+3.51%)
As of 11:31AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 138.42M
Enterprise value 118.05M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.78
Price/book (mrq)5.94
Enterprise value/revenue 2.63
Enterprise value/EBITDA -7.53

Trading information

Stock price history

Beta (5Y monthly) -0.13
52-week change 3-1.05%
S&P500 52-week change 325.01%
52-week high 36.2500
52-week low 32.7000
50-day moving average 33.9607
200-day moving average 34.7123

Share statistics

Avg vol (3-month) 3372.26k
Avg vol (10-day) 3258.08k
Shares outstanding 548.74M
Implied shares outstanding 648.74M
Float 828.91M
% held by insiders 110.16%
% held by institutions 176.67%
Shares short (28 Mar 2024) 4831.54k
Short ratio (28 Mar 2024) 42.1
Short % of float (28 Mar 2024) 43.02%
Short % of shares outstanding (28 Mar 2024) 41.71%
Shares short (prior month 29 Feb 2024) 4717.9k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -42.74%
Operating margin (ttm)-34.29%

Management effectiveness

Return on assets (ttm)-23.39%
Return on equity (ttm)-154.69%

Income statement

Revenue (ttm)44.85M
Revenue per share (ttm)1.02
Quarterly revenue growth (yoy)44.90%
Gross profit (ttm)N/A
EBITDA -17.68M
Net income avi to common (ttm)-19.17M
Diluted EPS (ttm)-0.4400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)46.22M
Total cash per share (mrq)0.95
Total debt (mrq)25.85M
Total debt/equity (mrq)110.83%
Current ratio (mrq)2.41
Book value per share (mrq)0.48

Cash flow statement

Operating cash flow (ttm)-15.44M
Levered free cash flow (ttm)-12.56M